These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 10652623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting the biologic behavior of ductal carcinoma in situ: an analysis of molecular markers.
    Hieken TJ, Farolan M, D'Alessandro S, Velasco JM.
    Surgery; 2001 Oct; 130(4):593-600; discussion 600-1. PubMed ID: 11602889
    [Abstract] [Full Text] [Related]

  • 3. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP, Prioleau JE, Harris JR, Schnitt SJ.
    Cancer; 1996 Feb 01; 77(3):499-506. PubMed ID: 8630957
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data.
    O'Malley FP, Vnencak-Jones CL, Dupont WD, Parl F, Manning S, Page DL.
    Lab Invest; 1994 Jul 01; 71(1):67-72. PubMed ID: 8041120
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Jul 01; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast.
    Vogl G, Dietze O, Hauser-Kronberger C.
    Histopathology; 2005 Dec 01; 47(6):617-24. PubMed ID: 16324200
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.
    Engels K, Fox SB, Whitehouse RM, Gatter KC, Harris AL.
    J Pathol; 1997 Feb 01; 181(2):207-12. PubMed ID: 9120727
    [Abstract] [Full Text] [Related]

  • 17. Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes.
    Maxhimer JB, Pesce CE, Stewart RA, Gattuso P, Prinz RA, Xu X.
    J Am Coll Surg; 2005 Mar 01; 200(3):328-35. PubMed ID: 15737842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S.
    J Am Coll Surg; 2004 Jan 01; 198(1):83-90. PubMed ID: 14698315
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.